Not yet recruiting
Adenocarcinoma gastric+3
Not yet recruitingStudy of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab
Registered drugNo placebo
Study of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab
Registered drugNo placebo
- Disease:Adenocarcinoma gastricColorectal cancer metastatic+2
- Substances:BMS-986340Nivolumab
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:BMS-986340
- Sponsor:Fondazione Humanitas Per La Ricerca Ets
